デフォルト表紙
市場調査レポート
商品コード
1538543

局所鎮痛剤市場レポート:2030年までの動向、予測、競合分析

Topical Pain Relief Market Report: Trends, Forecast and Competitive Analysis to 2030


出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

局所鎮痛剤市場レポート:2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

局所鎮痛剤の動向と予測

局所鎮痛剤の世界市場は、2024年から2030年までのCAGRが6.3%で、2030年までに推定125億米ドルに達すると予想されます。この市場の主な促進要因は、関節炎や筋骨格系疾患の罹患率の上昇、非薬理学的・非侵襲的治療に対する消費者の嗜好の拡大、セルフメディケーションに対する嗜好の高まりです。世界の局所鎮痛剤市場の将来は、病院薬局、小売薬局、ドラッグストア、オンラインプラットフォーム市場における機会によって有望視されています。

局所鎮痛剤:セグメント別

本調査では、局所鎮痛剤の世界市場をクラス別、形態別、流通チャネル別、地域別に予測しています。

局所鎮痛剤市場の洞察

Lucintel社は、予測期間中、オピオイド/麻薬はより大きなセグメントであり続けると予測しています。

この市場において、小売薬局は予測期間中最大のセグメントであり続けると予想されます。

北米は予測期間中最大の地域であり続けると予想されます。

よくある質問

Q1.市場規模は:

A1.世界の局所鎮痛剤市場は、2030年までに推定125億米ドルに達すると予想されています。

Q2.市場の成長予測は:

A2.世界の局所鎮痛剤市場は、2024年から2030年にかけてCAGR 6.3%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は:

A3.この市場の主な促進要因は、関節炎や筋骨格系疾患の罹患率の上昇、非薬理学的・非侵襲的治療に対する消費者の嗜好の拡大、セルフメディケーションに対する嗜好の高まりです。

Q4.市場の主要セグメントは:

A4.局所鎮痛剤市場の将来は、病院薬局、小売薬局、ドラッグストア、オンラインプラットフォーム市場において有望です。

Q5.市場の主要企業は:

A5.局所鎮痛剤の主要企業は以下の通り:

  • Johnson & Johnson
  • Sanofi
  • Topical Biomedics
  • Reckitt Benckiser Group
  • AdvaCare pharma
  • Pfizer
  • Novartis
  • Sun Pharmaceutical Industries
  • Nestle
  • GlaxoSmithKline

Q6.今後、最大となる市場セグメントは:

A6.Lucintelは、予測期間中、オピオイド/麻薬はより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は:

A7.予測期間中、北米が最大地域であり続けると予想されます。

Q8.レポートのカスタマイズは可能か:

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の局所鎮痛剤市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の局所鎮痛剤市場の動向(2018~2023年)と予測(2024~2030年)
  • クラス別の世界の局所鎮痛剤市場
    • オピオイド/麻薬
    • 非オピオイド
  • 形態別の世界の局所鎮痛剤市場
    • スプレー
    • パッチ
    • クリーム
    • フォーム
  • 流通チャネル別の世界の局所鎮痛剤市場
    • 病院薬局
    • 小売薬局
    • ドラッグストア
    • オンラインプラットフォーム
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の局所鎮痛剤市場
  • 北米の局所鎮痛剤市場
  • 欧州の局所鎮痛剤市場
  • アジア太平洋地域の局所鎮痛剤市場
  • その他地域の局所鎮痛剤市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
  • 世界の局所鎮痛剤市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の局所鎮痛剤市場の生産能力拡大
    • 世界の局所鎮痛剤市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Johnson & Johnson
  • Sanofi
  • Topical Biomedics
  • Reckitt Benckiser Group
  • AdvaCare pharma
  • Pfizer
  • Novartis
  • Sun Pharmaceutical Industries
  • Nestle
  • GlaxoSmithKline
目次

Topical Pain Relief Trends and Forecast

The future of the global topical pain relief market looks promising with opportunities in the hospital pharmacy, retail pharmacy, drug store, and online platform markets. The global topical pain relief market is expected to reach an estimated $12.5 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are escalating incidence of arthritis and musculoskeletal conditions, expanding consumer preference for non-pharmacological and non-invasive treatments, and augmenting preference for self-medication.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Topical Pain Relief by Segment

The study includes a forecast for the global topical pain relief by class, form, distributional channel, and region.

Topical Pain Relief Market by Class [Shipment Analysis by Value from 2018 to 2030]:

  • Opioids/Narcotics
  • Non-Opioids

Topical Pain Relief Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Sprays
  • Patches
  • Creams
  • Foams

Topical Pain Relief Market by Distributional Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Platforms
  • Others

Topical Pain Relief Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Topical Pain Relief Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies topical pain relief companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the topical pain relief companies profiled in this report include-

  • Johnson & Johnson
  • Sanofi
  • Topical Biomedics
  • Reckitt Benckiser Group
  • AdvaCare pharma
  • Pfizer
  • Novartis
  • Sun Pharmaceutical Industries
  • Nestle
  • GlaxoSmithKline

Topical Pain Relief Market Insights

Lucintel forecasts that opioid/narcotic will remain larger segment over the forecast period.

Within this market, retail pharmacy will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Topical Pain Relief Market

Market Size Estimates: Topical pain relief market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Topical pain relief market size by class, form, distributional channel, and region in terms of value ($B).

Regional Analysis: Topical pain relief market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different classes, forms, distributional channels, and regions for the topical pain relief market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the topical pain relief market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the topical pain relief market size?

Answer: The global topical pain relief market is expected to reach an estimated $12.5 billion by 2030.

Q2. What is the growth forecast for topical pain relief market?

Answer: The global topical pain relief market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the topical pain relief market?

Answer: The major drivers for this market are escalating incidence of arthritis and musculoskeletal conditions, expanding consumer preference for non-pharmacological and non-invasive treatments, and augmenting preference for self-medication.

Q4. What are the major segments for topical pain relief market?

Answer: The future of the topical pain relief market looks promising with opportunities in the hospital pharmacy, retail pharmacy, drug store, and online platform markets.

Q5. Who are the key topical pain relief market companies?

Answer: Some of the key topical pain relief companies are as follows:

  • Johnson & Johnson
  • Sanofi
  • Topical Biomedics
  • Reckitt Benckiser Group
  • AdvaCare pharma
  • Pfizer
  • Novartis
  • Sun Pharmaceutical Industries
  • Nestle
  • GlaxoSmithKline

Q6. Which topical pain relief market segment will be the largest in future?

Answer: Lucintel forecasts that opioid/narcotic will remain larger segment over the forecast period.

Q7. In topical pain relief market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the topical pain relief market by class (opioids/narcotics and non-opioids), form (sprays, patches, creams, and foams), distributional channel (hospital pharmacies, retail pharmacies, drug stores, online platforms, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Topical Pain Relief Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Topical Pain Relief Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Topical Pain Relief Market by Class
    • 3.3.1: Opioids/Narcotics
    • 3.3.2: Non-Opioids
  • 3.4: Global Topical Pain Relief Market by Form
    • 3.4.1: Sprays
    • 3.4.2: Patches
    • 3.4.3: Creams
    • 3.4.4: Foams
  • 3.5: Global Topical Pain Relief Market by Distributional Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Drug Stores
    • 3.5.4: Online Platforms
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Topical Pain Relief Market by Region
  • 4.2: North American Topical Pain Relief Market
    • 4.2.1: North American Topical Pain Relief Market by Class: Opioids/Narcotics and Non-Opioids
    • 4.2.2: North American Topical Pain Relief Market by Distributional Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, and Others
  • 4.3: European Topical Pain Relief Market
    • 4.3.1: European Topical Pain Relief Market by Class: Opioids/Narcotics and Non-Opioids
    • 4.3.2: European Topical Pain Relief Market by Distributional Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, and Others
  • 4.4: APAC Topical Pain Relief Market
    • 4.4.1: APAC Topical Pain Relief Market by Class: Opioids/Narcotics and Non-Opioids
    • 4.4.2: APAC Topical Pain Relief Market by Distributional Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, and Others
  • 4.5: ROW Topical Pain Relief Market
    • 4.5.1: ROW Topical Pain Relief Market by Class: Opioids/Narcotics and Non-Opioids
    • 4.5.2: ROW Topical Pain Relief Market by Distributional Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Topical Pain Relief Market by Class
    • 6.1.2: Growth Opportunities for the Global Topical Pain Relief Market by Form
    • 6.1.3: Growth Opportunities for the Global Topical Pain Relief Market by Distributional Channel
    • 6.1.4: Growth Opportunities for the Global Topical Pain Relief Market by Region
  • 6.2: Emerging Trends in the Global Topical Pain Relief Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Topical Pain Relief Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Topical Pain Relief Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Johnson & Johnson
  • 7.2: Sanofi
  • 7.3: Topical Biomedics
  • 7.4: Reckitt Benckiser Group
  • 7.5: AdvaCare pharma
  • 7.6: Pfizer
  • 7.7: Novartis
  • 7.8: Sun Pharmaceutical Industries
  • 7.9: Nestle
  • 7.10: GlaxoSmithKline